Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration

scientific article

Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1001/JAMA.2013.4997
P3181OpenCitations bibliographic resource ID278849
P698PubMed publication ID23644932

P433issue19
P407language of work or nameEnglishQ1860
P921main subjectfatty acidQ61476
macular degenerationQ27429789
eye diseaseQ3041498
P304page(s)2005
2005-15
P577publication date2013-05-15
P1433published inThe Journal of the American Medical AssociationQ1470970
P1476titleLutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration
Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration
Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial
P478volume309

Reverse relations

cites work (P2860)
Q64901264A Critical Appraisal of National and International Clinical Practice Guidelines Reporting Nutritional Recommendations for Age-Related Macular Degeneration: Are Recommendations Evidence-Based?
Q52818918A Deep Phenotype Association Study Reveals Specific Phenotype Associations with Genetic Variants in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 (AREDS2) Report No. 14.
Q33740158A Review of Current and Future Management of Geographic Atrophy
Q33914344A glimpse at the aging eye.
Q89752994A low glycemic diet protects disease-prone Nrf2-deficient mice against age-related macular degeneration
Q37417825A randomized controlled trial of omega-3 fatty acids in dry eye syndrome
Q38996375A review of the evidence for dietary interventions in preventing or slowing the progression of age-related macular degeneration
Q92599989A review of the putative causal mechanisms associated with lower macular pigment in diabetes mellitus
Q94468688A semi-automated machine-learning based workflow for ellipsoid zone analysis in eyes with macular edema: SCORE2 pilot study
Q92214955A systems biology approach towards understanding and treating non-neovascular age-related macular degeneration
Q57809996A two-year follow-up of oral antioxidant supplementation in primary open-angle glaucoma: an open-label, randomized, controlled trial
Q41641535AMD-like retinopathy associated with intravenous iron.
Q38636016Absolute and estimated values of macular pigment optical density in young and aged Asian participants with or without age-related macular degeneration.
Q33945202Addressing nutritional gaps with multivitamin and mineral supplements
Q36223020Adherence to a Mediterranean diet, genetic susceptibility, and progression to advanced macular degeneration: a prospective cohort study
Q38214725Advances in the management of macular degeneration
Q92848771Age-Related Macular Degeneration and Associated Risk Factors in the Population-Based Study of Health in Pomerania (SHIP-Trend)
Q26799617Age-Related Macular Degeneration: Advances in Management and Diagnosis
Q26823002Age-related Eye Disease Study 2: perspectives, recommendations, and unanswered questions
Q57299740Age-related macular degeneration
Q51807855Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: Rationale and study design of the ASPREE-AMD study.
Q37068063Age-related macular degeneration-clinical review and genetics update
Q37315838Aging is not a disease: distinguishing age-related macular degeneration from aging
Q38330232An Evidence-Based Systematic Review of Lutein by the Natural Standard Research Collaboration
Q57826003Antecedents of Soft Drusen, the Specific Deposits of Age-Related Macular Degeneration, in the Biology of Human Macula
Q24194251Anti-vascular endothelial growth factor for neovascular age-related macular degeneration
Q92133213Anti-vascular endothelial growth factor for neovascular age-related macular degeneration
Q38653249Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.
Q38169110Antioxidants and vision health: facts and fiction
Q36678494Assessment of lutein, zeaxanthin and meso-zeaxanthin concentrations in dietary supplements by chiral high-performance liquid chromatography
Q31143690Association of HDL-related loci with age-related macular degeneration and plasma lutein and zeaxanthin: the Alienor study
Q48553385Association of Mortality with Ocular Diseases and Visual Impairment in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 13.
Q57141419Association of obesity and age-related macular degeneration in Indian population
Q58691836Association of serum lutein and zeaxanthin with quantitative measures of retinal vascular parameters
Q40047525Associations Between Vitamin D Intake and Progression to Incident Advanced Age-Related Macular Degeneration
Q36617497Associations of human retinal very long-chain polyunsaturated fatty acids with dietary lipid biomarkers
Q55225281Attenuation of choroidal neovascularization by dietary intake of ω-3 long-chain polyunsaturated fatty acids and lutein in mice.
Q37607650Beneficial effects of the nutritional supplements on the development of diabetic retinopathy
Q39014462Benefits, Potential Harms, and Optimal Use of Nutritional Supplementation for Preventing Progression of Age-Related Macular Degeneration
Q34185581Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study
Q53124472Birdshot Retinochoroidopathy: Differences in Clinical Characteristics between Patients with Early and Late Age of Onset.
Q38877436Bivariate Analysis of Age-Related Macular Degeneration Progression Using Genetic Risk Scores
Q42374712Bone Marrow-Derived Cell Recruitment to the Neurosensory Retina and Retinal Pigment Epithelial Cell Layer Following Subthreshold Retinal Phototherapy
Q51758276C-Reactive Protein As a Mediator of Complement Activation and Inflammatory Signaling in Age-Related Macular Degeneration.
Q35679791CFH Y402H and ARMS2 A69S Polymorphisms and Oral Supplementation with Docosahexaenoic Acid in Neovascular Age-Related Macular Degeneration Patients: The NAT2 Study
Q36733416Can Xanthophyll-Membrane Interactions Explain Their Selective Presence in the Retina and Brain?
Q37286511Candidate gene study of macular response to supplemental lutein and zeaxanthin
Q38767261Cell-based therapeutic strategies for replacement and preservation in retinal degenerative diseases
Q64076578Cellular Signaling in Müller Glia: Progenitor Cells for Regenerative and Neuroprotective Responses in Pharmacological Models of Retinal Degeneration
Q37728614Central Retinal Enrichment Supplementation Trials (CREST): design and methodology of the CREST randomized controlled trials.
Q47637461Challenges in the Development of Therapy for Dry Age-Related Macular Degeneration
Q35801527Changes in Macular Pigment Optical Density and Serum Lutein Concentration in Japanese Subjects Taking Two Different Lutein Supplements
Q47097580Characterizing the effect of supplements on the phenotype of cultured macrophages from patients with age-related macular degeneration
Q33758267Cholesterol in the retina: the best is yet to come.
Q34930298Clinical characteristics and current treatment of age-related macular degeneration
Q37044220Cognitive Function and Its Relationship with Macular Pigment Optical Density and Serum Concentrations of its Constituent Carotenoids
Q89845989Combination of Lutein and Zeaxanthin, and DHA Regulated Polyunsaturated Fatty Acid Oxidation in H2O2-Stressed Retinal Cells
Q33849096Combined influence of poor health behaviours on the prevalence and 15-year incidence of age-related macular degeneration
Q38170996Common cell biologic and biochemical changes in aging and age-related diseases of the eye: toward new therapeutic approaches to age-related ocular diseases
Q35827351Comparison of Mouse and Human Retinal Pigment Epithelium Gene Expression Profiles: Potential Implications for Age-Related Macular Degeneration
Q54591303Comparison of macular pigment and serum lutein concentration changes between free lutein and lutein esters supplements in Japanese subjects.
Q41002492Comparison of macular pigment optical density in patients with dry and wet age-related macular degeneration
Q58702202Complement System and Age-Related Macular Degeneration: Implications of Gene-Environment Interaction for Preventive and Personalized Medicine
Q35118257Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy.
Q46022690Complement factor H in AMD: Bridging genetic associations and pathobiology.
Q38614012Complement pathway biomarkers and age-related macular degeneration.
Q90692198Correlation between Macular Pigment Optical Density and Neural Thickness and Volume of the Retina
Q33922277Correlations Between Macular, Skin, and Serum Carotenoids
Q38611218Cost-effectiveness of age-related macular degeneration study supplements in the UK: combined trial and real-world outcomes data
Q33897619Critical elevation of international normalized ratio in an elderly woman using a natural health product
Q26778247Current therapeutic developments in atrophic age-related macular degeneration
Q46372230Cytochrome P450 monooxygenase lipid metabolites are significant second messengers in the resolution of choroidal neovascularization
Q30583016Cytochrome P450-generated metabolites derived from ω-3 fatty acids attenuate neovascularization
Q90663721Cytoprotective Effects of Natural Highly Bio-Available Vegetable Derivatives on Human-Derived Retinal Cells
Q61812842Development and Validation of a LC⁻MS/MS-Based Assay for Quantification of Free and Total Omega 3 and 6 Fatty Acids from Human Plasma
Q64928522Dietary Antioxidants, Macular Pigment, and Glaucomatous Neurodegeneration: A Review of the Evidence.
Q57134980Dietary Consumption of Lutein and Zeaxanthin in Panama: A Cross-Sectional Study
Q92210536Dietary Habits, Fatty Acids and Carotenoid Levels Are Associated with Neovascular Age-Related Macular Degeneration in Chinese
Q39116210Dietary Intakes of Eicosapentaenoic Acid and Docosahexaenoic Acid and Risk of Age-Related Macular Degeneration
Q64890273Dietary Patterns and Age-Related Macular Degeneration in Korea: The Korea National Health and Nutrition Examination Survey 2010-2011.
Q99605502Dietary Patterns, Carbohydrates, and Age-Related Eye Diseases
Q34884403Dietary bioactives: establishing a scientific framework for recommended intakes
Q36728621Dietary folate, B vitamins, genetic susceptibility and progression to advanced nonexudative age-related macular degeneration with geographic atrophy: a prospective cohort study
Q47106416Dietary guidance for lutein: consideration for intake recommendations is scientifically supported
Q64247384Dietary intervention in patients with age-related macular degeneration: protocol for a randomised controlled trial
Q38529695Dietary modification and supplementation for the treatment of age-related macular degeneration
Q36549148Dietary n-3 Fatty Acid, α-Tocopherol, Zinc, vitamin D, vitamin C, and β-carotene are Associated with Age-Related Macular Degeneration in Japan
Q35652661Dietary supplement enriched in antioxidants and omega-3 protects from progressive light-induced retinal degeneration
Q30251418Dietary supplements and disease prevention - a global overview.
Q89480311Differential composition of DHA and very-long-chain PUFAs in rod and cone photoreceptors
Q39167698Dissecting microRNA dysregulation in age-related macular degeneration: new targets for eye gene therapy
Q21284507Do nutritional supplements have a role in age macular degeneration prevention?
Q38253067Drugs in Phase II clinical trials for the treatment of age-related macular degeneration
Q38786743Drusen maculopathy: a risk factor for visual deterioration
Q38789140Dry Age-Related Macular Degeneration Pharmacology
Q35930987Dynamic Drusen Remodelling in Participants of the Nutritional AMD Treatment-2 (NAT-2) Randomized Trial
Q42373141Early and intermediate age-related macular degeneration: update and clinical review.
Q64930030Effect of Long-Term Xanthophyll and Anthocyanin Supplementation on Lutein and Zeaxanthin Serum Concentrations and Macular Pigment Optical Density in Postmenopausal Women.
Q34490891Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial
Q96683775Effect of an antioxidant supplement containing high dose lutein and zeaxanthin on macular pigment and skin carotenoid levels
Q58739721Effect of omega 3 fatty acids on C-reactive protein and interleukin-6 in patients with advanced nonsmall cell lung cancer
Q41845904Effect of supplemental lutein and zeaxanthin on serum, macular pigmentation, and visual performance in patients with early age-related macular degeneration
Q91584129Effects of Lutein Supplementation in Japanese Patients with Unilateral Age-Related Macular Degeneration: The Sakai Lutein Study
Q93055205Effects of Macuprev® Supplementation in Age-Related Macular Degeneration: A Double-Blind Randomized Morpho-Functional Study Along 6 Months of Follow-Up
Q37624757Effects of multivitamin supplement on cataract and age-related macular degeneration in a randomized trial of male physicians
Q64898355Efficacy and Safety of Lampalizumab for Geographic Atrophy Due to Age-Related Macular Degeneration: Chroma and Spectri Phase 3 Randomized Clinical Trials.
Q38421723Efficacy and Safety of Saffron Supplementation: Current Clinical Findings
Q34425459Efficacy of Multivitamin/mineral Supplementation to Reduce Chronic Disease Risk: A Critical Review of the Evidence from Observational Studies and Randomized Controlled Trials
Q47124297Efficacy of a Fatty Acids Dietary Supplement in a Polyethylene Glycol-Induced Mouse Model of Retinal Degeneration
Q36738021Elevated Fundus Autofluorescence in Monkeys Deficient in Lutein, Zeaxanthin, and Omega-3 Fatty Acids
Q47128247Enhancing the efficacy of AREDS antioxidants in light-induced retinal degeneration
Q34353014European survey on the opinion and use of micronutrition in age-related macular degeneration: 10 years on from the Age-Related Eye Disease Study
Q37472652Evaluating Potential Therapies in a Mouse Model of Focal Retinal Degeneration with Age-related Macular Degeneration (AMD)-Like Lesions
Q46241948Evaluating role of bone marrow-derived stem cells in dry age-related macular degeneration using multifocal electroretinogram and fundus autofluorescence imaging
Q40048038Evaluation of Approaches to Analyzing Continuous Correlated Eye Data When Sample Size Is Small
Q41677822Evaluation of a clinical decision-making aid for nutrition advice in age-related macular degeneration.
Q36525901Evaluation of an oral telomerase activator for early age-related macular degeneration - a pilot study
Q52559837Exploring the Use of Molecular Biomarkers for Precision Medicine in Age-Related Macular Degeneration.
Q51144972Factors influencing self-reported use of antioxidant supplements in patients with age-related macular degeneration.
Q55492700Fatty Acids Dietary Supplements Exert Anti-Inflammatory Action and Limit Ganglion Cell Degeneration in the Retina of the EAE Mouse Model of Multiple Sclerosis.
Q33452521Feasibility of Use of a Mobile Application for Nutrition Assessment Pertinent to Age-Related Macular Degeneration (MANAGER2)
Q36205759Features of Age-Related Macular Degeneration in the General Adults and Their Dependency on Age, Sex, and Smoking: Results from the German KORA Study
Q28066446Fish Consumption and Age-Related Macular Degeneration Incidence: A Meta-Analysis and Systematic Review of Prospective Cohort Studies
Q34090408Five-year incidence, progression, and risk factors for age-related macular degeneration: the age, gene/environment susceptibility study
Q89440936Food groups and risk of age-related macular degeneration: a systematic review with meta-analysis
Q57297134Further Evidence on Efficacy of Diet Supplementation with Fatty Acids in Ocular Pathologies: Insights from the EAE Model of Optic Neuritis
Q38596855Gene-Diet Interactions in Age-Related Macular Degeneration
Q27013719Genetic and environmental underpinnings to age-related ocular diseases
Q37537304Genetic evidence for role of carotenoids in age-related macular degeneration in the Carotenoids in Age-Related Eye Disease Study (CAREDS).
Q26738526Genetics and age-related macular degeneration: a practical review for the clinician
Q48326680Genetics and genetic testing for age-related macular degeneration.
Q28074640Geographic Atrophy and Choroidal Neovascularization in the Same Eye: A Review
Q35573017Gossypol Acetic Acid Prevents Oxidative Stress-Induced Retinal Pigment Epithelial Necrosis by Regulating the FoxO3/Sestrin2 Pathway
Q30276550Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue
Q36196897Gut microbiota influences pathological angiogenesis in obesity-driven choroidal neovascularization
Q44857437HYPERSPECTRAL AUTOFLUORESCENCE IMAGING OF DRUSEN AND RETINAL PIGMENT EPITHELIUM IN DONOR EYES WITH AGE-RELATED MACULAR DEGENERATION.
Q64229464Health Benefits of Polyphenols and Carotenoids in Age-Related Eye Diseases
Q37654216Healthcare experiences of patients with age-related macular degeneration: have things improved? Cross-sectional survey responses of Macular Society members in 2013 compared with 1999.
Q89715398Higher Intake of Polyunsaturated Fatty Acid and Monounsaturated Fatty Acid is Inversely Associated With AMD
Q98563377Home Monitoring of Age-Related Macular Degeneration: Real-World Utility of the ForeseeHome Device for Detection of Neovascularization
Q91588038Human Plasma Metabolomics in Age-Related Macular Degeneration: Meta-Analysis of Two Cohorts
Q58761997Imidazole Compounds for Protecting Choroidal Endothelial Cells from Complement Injury
Q92244364Implantation of Scharioth macula lens in patients with age-related macular degeneration: results of a prospective European multicentre clinical trial
Q39043636Induction of necrotic cell death by oxidative stress in retinal pigment epithelial cells
Q45354500Inflammaging: should this term be suitable for age related macular degeneration too?
Q35755942Inflammatory Mechanisms of Age-related Macular Degeneration
Q30829406Intakes of Lutein, Zeaxanthin, and Other Carotenoids and Age-Related Macular Degeneration During 2 Decades of Prospective Follow-up
Q33739755Intravitreal use of bone marrow mononuclear fraction containing CD34+ stem cells in patients with atrophic age-related macular degeneration
Q57177518Intrinsic and Extrinsic Factors Impacting Absorption, Metabolism, and Health Effects of Dietary Carotenoids
Q92269896Investigating the potential of Zernike polynomials to characterise spatial distribution of macular pigment
Q44870873Involvement of a gut-retina axis in protection against dietary glycemia-induced age-related macular degeneration.
Q64075478Is Grassfed Meat and Dairy Better for Human and Environmental Health?
Q38192127Is age-related macular degeneration a manifestation of systemic disease? New prospects for early intervention and treatment
Q36468066Joint Associations of Diet, Lifestyle, and Genes with Age-Related Macular Degeneration
Q40703905Light, lipids and photoreceptor survival: live or let die?
Q38915148Lipids, oxidized lipids, oxidation-specific epitopes, and Age-related Macular Degeneration
Q89831192Long-term Evolution and Remodeling of Soft Drusen in Rhesus Macaques
Q92008650Lutein across the Lifespan: From Childhood Cognitive Performance to the Aging Eye and Brain
Q37117609Lutein acts via multiple antioxidant pathways in the photo-stressed retina
Q38901504Lutein and Zeaxanthin Isomers in Eye Health and Disease
Q24185832Lutein and zeaxanthin for reducing morbidity and mortality in preterm infants
Q41111119Lutein and zeaxanthin isomers modulates lipid metabolism and the inflammatory state of retina in obesity-induced high-fat diet rodent model.
Q48364825Lutein improves cell viability and reduces Alu RNA accumulation in hydrogen peroxide challenged retinal pigment epithelial cells
Q30693939Lutein, zeaxanthin, and meso-zeaxanthin: The basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease
Q37673168Lutein and Zeaxanthin-Food Sources, Bioavailability  and Dietary Variety in Age-Related Macular  Degeneration Protection
Q35075333Lycium barbarum polysaccharides protected human retinal pigment epithelial cells against oxidative stress-induced apoptosis
Q37636009Macular Pigment Optical Density and Measures of Macular Function: Test-Retest Variability, Cross-Sectional Correlations, and Findings from the Zeaxanthin Pilot Study of Response to Supplementation (ZEASTRESS-Pilot).
Q89588604Macular Pigment Optical Density in the Korean Population: a Cross Sectional Study
Q34544965Macular carotenoid supplementation improves disability glare performance and dynamics of photostress recovery
Q41918704Macular pigment and its contribution to vision.
Q39231679Macular pigment and macular volume in eyes of patients with cystic fibrosis
Q28072398Macular pigment in retinal health and disease
Q37229764Macular pigment optical density: repeatability, intereye correlation, and effect of ocular dominance
Q34443359Macular response to supplementation with differing xanthophyll formulations in subjects with and without age-related macular degeneration
Q26776069Management of Ocular Diseases Using Lutein and Zeaxanthin: What Have We Learned from Experimental Animal Studies?
Q26824335Management of neovascular age-related macular degeneration: current state-of-the-art care for optimizing visual outcomes and therapies in development
Q38751193Mechanisms of selective delivery of xanthophylls to retinal pigment epithelial cells by human lipoproteins
Q38606762Melissa Officinalis L. Extracts Protect Human Retinal Pigment Epithelial Cells against Oxidative Stress-Induced Apoptosis
Q34531240Mice that produce ApoB100 lipoproteins in the RPE do not develop drusen yet are still a valuable experimental system
Q91660747Microvascular contributions to age-related macular degeneration (AMD): from mechanisms of choriocapillaris aging to novel interventions
Q35685717Modifying Choroidal Neovascularization Development with a Nutritional Supplement in Mice
Q26860718Molecular complexes that direct rhodopsin transport to primary cilia
Q26995315NLRP3 inflammasome: activation and regulation in age-related macular degeneration
Q38174408Nature and nurture- genes and environment- predict onset and progression of macular degeneration.
Q26749178Neuroprotection as a Therapeutic Target for Diabetic Retinopathy
Q52699533New GABA modulators protect photoreceptor cells from light-induced degeneration in mouse models.
Q26776523Nitroxide pharmaceutical development for age-related degeneration and disease
Q35111445Novel Nrf2 activators from microbial transformation products inhibit blood-retinal barrier permeability in rabbits.
Q36941812Nutraceutical with Resveratrol and Omega-3 Fatty Acids Induces Autophagy in ARPE-19 Cells
Q26821899Nutrient Supplementation for Age-related Macular Degeneration, Cataract, and Dry Eye
Q27015832Nutrients for the aging eye
Q34132062Nutrition effects on ocular diseases in the aging eye.
Q93118085Nutrition interventions for healthy ageing across the lifespan: a conference report
Q38800270Nutrition, Genes, and Age-Related Macular Degeneration: What Have We Learned from the Trials?
Q89687694Nutritional Supplements for Age-Related Macular Degeneration
Q58699164Nutritional Value of the Duckweed Species of the Genus (Lemnaceae) as Human Food
Q37592954Nutritional and Lifestyle Interventions for Age-Related Macular Degeneration: A Review
Q49608613Nutritional and smoking advice recalled by patients attending a UK age-related macular degeneration clinic.
Q33914583Nutritional risk factors for age-related macular degeneration.
Q38317289Nutritional supplements in age-related macular degeneration
Q24186584Omega 3 fatty acids for preventing or slowing the progression of age-related macular degeneration
Q64227433Omega-3 and ranibizumab for age-related macular degeneration: A systematic review protocol
Q55919856Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Q89958068Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Q90307768Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Q58698899Omega-3 from Flaxseed Oil Protects Obese Mice Against Diabetic Retinopathy Through GPR120 Receptor
Q35316532Omega-3 supplementation combined with anti-vascular endothelial growth factor lowers vitreal levels of vascular endothelial growth factor in wet age-related macular degeneration
Q38873518One protein, multiple pathologies: multifaceted involvement of amyloid β in neurodegenerative disorders of the brain and retina.
Q38605292Optical Coherence Tomography Predictors of Risk for Progression to Non-Neovascular Atrophic Age-Related Macular Degeneration
Q96155742Optimisation of a Novel Bio-Substrate as a Treatment for Atrophic Age-Related Macular Degeneration
Q37338182Overall skin tone and skin-lightening-improving effects with oral supplementation of lutein and zeaxanthin isomers: a double-blind, placebo-controlled clinical trial
Q37708674Oxidative stress and its downstream signaling in aging eyes.
Q46248374Oxidative stress and reactive oxygen species: a review of their role in ocular disease
Q46824949Oxidative stress in dry age-related macular degeneration and exfoliation syndrome
Q36890365Perspective: A Critical Look at the Ancillary Age-Related Eye Disease Study 2: Nutrition and Cognitive Function Results in Older Individuals with Age-Related Macular Degeneration
Q38510019Pharmacogenetics and nutritional supplementation in age-related macular degeneration
Q38551646Photo-damage, photo-protection and age-related macular degeneration.
Q38921719Plasma long-chain omega-3 polyunsaturated fatty acids and macular pigment in subjects with family history of age-related macular degeneration: the Limpia Study
Q40396176Precursors of age-related macular degeneration: associations with vitamin A and interaction with CFHY402H in the Inter99 Eye Study
Q99239361Predicting risk of late age-related macular degeneration using deep learning
Q33845330Press releases issued by supplements industry organisations and non-industry organisations in response to publication of clinical research findings: a case-control study.
Q35899608Prevalence of age-related macular degeneration in the Republic of Ireland.
Q34395891Proof of concept, randomized, placebo-controlled study of the effect of simvastatin on the course of age-related macular degeneration
Q88007907Prophylactic laser in age-related macular degeneration: the past, the present and the future
Q59798752Protective Effects of Extracts on UVB-Induced Damage in Human Retinal Pigment Epithelial Cells Accompanied by Attenuating ROS and DNA Damage
Q55646884Proteomics of Human Retinal Pigment Epithelium (RPE) Cells.
Q39148545Putative protective role of lutein and zeaxanthin in diabetic retinopathy
Q61798257Quantification of Lutein + Zeaxanthin Presence in Human Placenta and Correlations with Blood Levels and Maternal Dietary Intake
Q35865877REPRODUCIBILITY OF MACULAR PIGMENT OPTICAL DENSITY MEASUREMENT BY TWO-WAVELENGTH AUTOFLUORESCENCE IN A CLINICAL SETTING.
Q27693234RPE necroptosis in response to oxidative stress and in AMD
Q37570185Randomized trial of a home monitoring system for early detection of choroidal neovascularization home monitoring of the Eye (HOME) study
Q38528148Ranibizumab and aflibercept for the treatment of wet age-related macular degeneration
Q36377333Recent advances in the management of dry age-related macular degeneration: A review
Q41532061Recent developments in age-related macular degeneration: a review.
Q28088816Recent developments in the management of dry age-related macular degeneration
Q26751293Regulation of signaling events involved in the pathophysiology of neovascular AMD
Q90462769Resvega Alleviates Hydroquinone-Induced Oxidative Stress in ARPE-19 Cells
Q38749961Retinal disease in the C3 glomerulopathies and the risk of impaired vision.
Q37164303Retinal pigment epithelial cell necroptosis in response to sodium iodate
Q48178677Retinal pigment epithelium in the pathogenesis of age-related macular degeneration and photobiomodulation as a potential therapy?
Q39262744Rheopheresis in vascular diseases
Q89888023Risk factors for progression of age-related macular degeneration
Q52326632Rod-Mediated Dark Adaptation and Macular Pigment Optical Density in Older Adults with Normal Maculas.
Q37298565Role of antioxidant enzymes and small molecular weight antioxidants in the pathogenesis of age-related macular degeneration (AMD)
Q28245638Role of lutein and zeaxanthin in visual and cognitive function throughout the lifespan
Q38211245Saffron and retina: neuroprotection and pharmacokinetics.
Q57808075Saffron therapy for the treatment of mild/moderate age-related macular degeneration: a randomised clinical trial
Q36257030Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3
Q92751432Serum 25-Hydroxyvitamin D Concentrations and Incidence of Age-Related Macular Degeneration: The Atherosclerosis Risk in Communities Study
Q93088623Skin Carotenoid Index in a large Japanese population sample
Q34394380Smoking and age-related macular degeneration: review and update
Q35230959Smoking, antioxidant supplementation and dietary intakes among older adults with age-related macular degeneration over 10 years
Q38975097Structural and molecular changes in the aging choroid: implications for age-related macular degeneration
Q36401339Suboptimal Plasma Long Chain n-3 Concentrations are Common among Adults in the United States, NHANES 2003-2004.
Q92816070Suppression of AMD-Like Pathology by Mitochondria-Targeted Antioxidant SkQ1 Is Associated with a Decrease in the Accumulation of Amyloid β and in mTOR Activity
Q34476425Sustained supplementation and monitored response with differing carotenoid formulations in early age-related macular degeneration
Q36586130Synthesis of docosahexaenoic acid from eicosapentaenoic acid in retina neurons protects photoreceptors from oxidative stress
Q93157135Systematic review of the appropriateness of eye care delivery in eye care practice
Q36123333Systemic confounders affecting serum measurements of omega-3 and -6 polyunsaturated fatty acids in patients with retinal disease.
Q39092535The Age-Related Eye Disease 2 Study: Micronutrients in the Treatment of Macular Degeneration
Q35716443The Clinical Effectiveness and Cost-Effectiveness of Screening for Age-Related Macular Degeneration in Japan: A Markov Modeling Study
Q93023744The Common Antidiabetic Drug Metformin Reduces Odds of Developing Age-Related Macular Degeneration
Q35596762The Effect of BCMO1 Gene Variants on Macular Pigment Optical Density in Young Healthy Caucasians.
Q58722677The Effect of Lutein on Eye and Extra-Eye Health
Q92221622The Effects of Lutein and Zeaxanthin Supplementation on Brain Morphology in Older Adults: A Randomized, Controlled Trial
Q55224872The Evolving Role of Multivitamin/Multimineral Supplement Use among Adults in the Age of Personalized Nutrition.
Q38692816The Pharmacological Effects of Lutein and Zeaxanthin on Visual Disorders and Cognition Diseases.
Q26769895The Photobiology of Lutein and Zeaxanthin in the Eye
Q50103461The Role of Diet in Glaucoma: A Review of the Current Evidence.
Q58611705The Role of Diet, Micronutrients and the Gut Microbiota in Age-Related Macular Degeneration: New Perspectives from the Gut⁻Retina Axis
Q92982650The Role of Fish Oil in Inflammatory Eye Diseases
Q45975184The Role of Mitochondria in AMD: Current Knowledge and Future Applications.
Q61806326The Role of Nutrients in Reducing the Risk for Noncommunicable Diseases during Aging
Q37406856The Royal College of Ophthalmologists Guidelines on AMD: Executive Summary
Q26749297The Treatment Paradigm for the Implantable Miniature Telescope
Q92354128The cGAS/STING pathway: a sensor of senescence-associated DNA damage and trigger of inflammation in early age-related macular degeneration
Q35133394The effect of modified eggs and an egg-yolk based beverage on serum lutein and zeaxanthin concentrations and macular pigment optical density: results from a randomized trial
Q37639903The evidence informing the surgeon's selection of intraocular lens on the basis of light transmittance properties.
Q57186574The impact of lipids, lipid oxidation, and inflammation on AMD, and the potential role of miRNAs on lipid metabolism in the RPE
Q39197341The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD.
Q38724013The influence of substrate modulus on retinal pigment epithelial cells
Q36111784The marine n-3 PUFA DHA evokes cytoprotection against oxidative stress and protein misfolding by inducing autophagy and NFE2L2 in human retinal pigment epithelial cells
Q35895835The novel triterpenoid RTA 408 protects human retinal pigment epithelial cells against H2O2-induced cell injury via NF-E2-related factor 2 (Nrf2) activation
Q35106624The relationship between BCMO1 gene variants and macular pigment optical density in persons with and without age-related macular degeneration
Q33914613The relationship of major American dietary patterns to age-related macular degeneration
Q38209275The role of proteases and inflammatory molecules in triggering neovascular age-related macular degeneration: basic science to clinical relevance
Q37646779The role of the complement system in age-related macular degeneration
Q35465063The self-reported clinical practice behaviors of Australian optometrists as related to smoking, diet and nutritional supplementation
Q28085495The stereotypical molecular cascade in neovascular age-related macular degeneration: the role of dynamic reciprocity
Q40775624The value of multifocal electroretinography to predict progressive visual acuity loss in early AMD.
Q38978374Tolerability in the elderly population of high-dose alpha lipoic acid: a potential antioxidant therapy for the eye.
Q89455914Trapa bispinosa Roxb. and lutein ameliorate cataract in type 1 diabetic rats
Q88878935Treatment of Geographic Atrophy with Intravitreal Sirolimus: The Age-Related Eye Disease Study 2 Ancillary Study
Q37304930Tropical bat as mammalian model for skin carotenoid metabolism
Q26767098Update on Clinical Trials in Dry Age-related Macular Degeneration
Q34366170Update on current and future novel therapies for dry age-related macular degeneration
Q30843382Using current data to define new approach in age related macular degeneration: need to accelerate translational research
Q35112300Verification of Meso-Zeaxanthin in Fish.
Q33717538Visual acuity after cataract surgery in patients with age-related macular degeneration: age-related eye disease study 2 report number 5.
Q34325624Visual function assessment in simulated real-life situations in patients with age-related macular degeneration compared to normal subjects.
Q37715254Visualization of Dietary Patterns and Their Associations With Age-Related Macular Degeneration
Q36866107Vitamin A-aldehyde adducts: AMD risk and targeted therapeutics
Q47100212Vitamin D and Age-Related Macular Degeneration
Q35476986Vitamin D deficiency in neovascular versus nonneovascular age-related macular degeneration
Q37557154Why fish oil fails: a comprehensive 21st century lipids-based physiologic analysis
Q45072584Xanthophylls lutein and zeaxanthin modify gene expression and induce synthesis of hyaluronan in keratinocyte model of human skin
Q37261208Zeaxanthin Induces Apoptosis in Human Uveal Melanoma Cells through Bcl-2 Family Proteins and Intrinsic Apoptosis Pathway
Q41843418Zeaxanthin inhibits hypoxia-induced VEGF secretion by RPE cells through decreased protein levels of hypoxia-inducible factors-1α.
Q46531483Zeaxanthin-based dietary supplement and topical serum improve hydration and reduce wrinkle count in female subjects
Q34506404Zinc supplementation inhibits complement activation in age-related macular degeneration
Q86603541[Supplements in age-related macular degeneration: recommendations by the German Ophthalmological Society, the German Retina Society and the German Professional Association of Ophthalmologists--October 2014]
Q33897623Élévation critique du rapport normalisé international chez une femme de 89 ans qui consomme un produit de santé naturel

Search more.